3 Safest Stocks to Buy Now
With the S&P 500 now in correction and stocks selling…
Sell
46
PTH Quote, Financials, Valuation and Earnings
Last price:
$38.00
Seasonality move
:
3.32%
Day range:
$38.02 - $38.89
52-week range:
$38.02 - $48.63
Dividend yield:
0.07%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
8.6K
Avg. volume:
16.1K
1-year change:
-13.67%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
PTH
Invesco Dorsey Wright Healthcare Momentum ETF
|
-- | -- | -- | -- | -- |
|
BBH
VanEck Biotech ETF
|
-- | -- | -- | -- | -- |
|
BBP
Virtus LifeSci Biotech Products ETF
|
-- | -- | -- | -- | -- |
|
PSCH
Invesco S&P SmallCap Health Care ETF
|
-- | -- | -- | -- | -- |
|
SBIO
ALPS Medical Breakthroughs ETF
|
-- | -- | -- | -- | -- |
|
XBI
SPDR S&P Biotech ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
PTH
Invesco Dorsey Wright Healthcare Momentum ETF
|
$38.27 | -- | -- | -- | $0.03 | 0.07% | -- |
|
BBH
VanEck Biotech ETF
|
$161.06 | -- | -- | -- | $1.25 | 0.78% | -- |
|
BBP
Virtus LifeSci Biotech Products ETF
|
$59.56 | -- | -- | -- | $0.00 | 0% | -- |
|
PSCH
Invesco S&P SmallCap Health Care ETF
|
$41.00 | -- | -- | -- | $0.02 | 0.29% | -- |
|
SBIO
ALPS Medical Breakthroughs ETF
|
$30.47 | -- | -- | -- | $1.17 | 3.85% | -- |
|
XBI
SPDR S&P Biotech ETF
|
$87.15 | -- | -- | -- | $0.00 | 0.15% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
PTH
Invesco Dorsey Wright Healthcare Momentum ETF
|
-- | 1.594 | -- | -- |
|
BBH
VanEck Biotech ETF
|
-- | 1.155 | -- | -- |
|
BBP
Virtus LifeSci Biotech Products ETF
|
-- | 1.217 | -- | -- |
|
PSCH
Invesco S&P SmallCap Health Care ETF
|
-- | 2.008 | -- | -- |
|
SBIO
ALPS Medical Breakthroughs ETF
|
-- | 1.265 | -- | -- |
|
XBI
SPDR S&P Biotech ETF
|
-- | 1.588 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
PTH
Invesco Dorsey Wright Healthcare Momentum ETF
|
-- | -- | -- | -- | -- | -- |
|
BBH
VanEck Biotech ETF
|
-- | -- | -- | -- | -- | -- |
|
BBP
Virtus LifeSci Biotech Products ETF
|
-- | -- | -- | -- | -- | -- |
|
PSCH
Invesco S&P SmallCap Health Care ETF
|
-- | -- | -- | -- | -- | -- |
|
SBIO
ALPS Medical Breakthroughs ETF
|
-- | -- | -- | -- | -- | -- |
|
XBI
SPDR S&P Biotech ETF
|
-- | -- | -- | -- | -- | -- |
Invesco Dorsey Wright Healthcare Momentum ETF vs. Competitors
-
Which has Higher Returns PTH or BBH?
VanEck Biotech ETF has a net margin of -- compared to Invesco Dorsey Wright Healthcare Momentum ETF's net margin of --. Invesco Dorsey Wright Healthcare Momentum ETF's return on equity of -- beat VanEck Biotech ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PTHInvesco Dorsey Wright Healthcare Momentum ETF-- -- -- BBHVanEck Biotech ETF-- -- -- -
What do Analysts Say About PTH or BBH?
Invesco Dorsey Wright Healthcare Momentum ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand VanEck Biotech ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco Dorsey Wright Healthcare Momentum ETF has higher upside potential than VanEck Biotech ETF, analysts believe Invesco Dorsey Wright Healthcare Momentum ETF is more attractive than VanEck Biotech ETF.
Company Buy Ratings Hold Ratings Sell Ratings PTHInvesco Dorsey Wright Healthcare Momentum ETF0 0 0 BBHVanEck Biotech ETF0 0 0 -
Is PTH or BBH More Risky?
Invesco Dorsey Wright Healthcare Momentum ETF has a beta of 0.902, which suggesting that the stock is 9.824% less volatile than S&P 500. In comparison VanEck Biotech ETF has a beta of 0.789, suggesting its less volatile than the S&P 500 by 21.104%.
-
Which is a Better Dividend Stock PTH or BBH?
Invesco Dorsey Wright Healthcare Momentum ETF has a quarterly dividend of $0.03 per share corresponding to a yield of 0.07%. VanEck Biotech ETF offers a yield of 0.78% to investors and pays a quarterly dividend of $1.25 per share. Invesco Dorsey Wright Healthcare Momentum ETF pays -- of its earnings as a dividend. VanEck Biotech ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PTH or BBH?
Invesco Dorsey Wright Healthcare Momentum ETF quarterly revenues are --, which are smaller than VanEck Biotech ETF quarterly revenues of --. Invesco Dorsey Wright Healthcare Momentum ETF's net income of -- is lower than VanEck Biotech ETF's net income of --. Notably, Invesco Dorsey Wright Healthcare Momentum ETF's price-to-earnings ratio is -- while VanEck Biotech ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco Dorsey Wright Healthcare Momentum ETF is -- versus -- for VanEck Biotech ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PTHInvesco Dorsey Wright Healthcare Momentum ETF-- -- -- -- BBHVanEck Biotech ETF-- -- -- --
-
Which has Higher Returns PTH or BBP?
Virtus LifeSci Biotech Products ETF has a net margin of -- compared to Invesco Dorsey Wright Healthcare Momentum ETF's net margin of --. Invesco Dorsey Wright Healthcare Momentum ETF's return on equity of -- beat Virtus LifeSci Biotech Products ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PTHInvesco Dorsey Wright Healthcare Momentum ETF-- -- -- BBPVirtus LifeSci Biotech Products ETF-- -- -- -
What do Analysts Say About PTH or BBP?
Invesco Dorsey Wright Healthcare Momentum ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Virtus LifeSci Biotech Products ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco Dorsey Wright Healthcare Momentum ETF has higher upside potential than Virtus LifeSci Biotech Products ETF, analysts believe Invesco Dorsey Wright Healthcare Momentum ETF is more attractive than Virtus LifeSci Biotech Products ETF.
Company Buy Ratings Hold Ratings Sell Ratings PTHInvesco Dorsey Wright Healthcare Momentum ETF0 0 0 BBPVirtus LifeSci Biotech Products ETF0 0 0 -
Is PTH or BBP More Risky?
Invesco Dorsey Wright Healthcare Momentum ETF has a beta of 0.902, which suggesting that the stock is 9.824% less volatile than S&P 500. In comparison Virtus LifeSci Biotech Products ETF has a beta of 0.678, suggesting its less volatile than the S&P 500 by 32.175%.
-
Which is a Better Dividend Stock PTH or BBP?
Invesco Dorsey Wright Healthcare Momentum ETF has a quarterly dividend of $0.03 per share corresponding to a yield of 0.07%. Virtus LifeSci Biotech Products ETF offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Invesco Dorsey Wright Healthcare Momentum ETF pays -- of its earnings as a dividend. Virtus LifeSci Biotech Products ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PTH or BBP?
Invesco Dorsey Wright Healthcare Momentum ETF quarterly revenues are --, which are smaller than Virtus LifeSci Biotech Products ETF quarterly revenues of --. Invesco Dorsey Wright Healthcare Momentum ETF's net income of -- is lower than Virtus LifeSci Biotech Products ETF's net income of --. Notably, Invesco Dorsey Wright Healthcare Momentum ETF's price-to-earnings ratio is -- while Virtus LifeSci Biotech Products ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco Dorsey Wright Healthcare Momentum ETF is -- versus -- for Virtus LifeSci Biotech Products ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PTHInvesco Dorsey Wright Healthcare Momentum ETF-- -- -- -- BBPVirtus LifeSci Biotech Products ETF-- -- -- --
-
Which has Higher Returns PTH or PSCH?
Invesco S&P SmallCap Health Care ETF has a net margin of -- compared to Invesco Dorsey Wright Healthcare Momentum ETF's net margin of --. Invesco Dorsey Wright Healthcare Momentum ETF's return on equity of -- beat Invesco S&P SmallCap Health Care ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PTHInvesco Dorsey Wright Healthcare Momentum ETF-- -- -- PSCHInvesco S&P SmallCap Health Care ETF-- -- -- -
What do Analysts Say About PTH or PSCH?
Invesco Dorsey Wright Healthcare Momentum ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco S&P SmallCap Health Care ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco Dorsey Wright Healthcare Momentum ETF has higher upside potential than Invesco S&P SmallCap Health Care ETF, analysts believe Invesco Dorsey Wright Healthcare Momentum ETF is more attractive than Invesco S&P SmallCap Health Care ETF.
Company Buy Ratings Hold Ratings Sell Ratings PTHInvesco Dorsey Wright Healthcare Momentum ETF0 0 0 PSCHInvesco S&P SmallCap Health Care ETF0 0 0 -
Is PTH or PSCH More Risky?
Invesco Dorsey Wright Healthcare Momentum ETF has a beta of 0.902, which suggesting that the stock is 9.824% less volatile than S&P 500. In comparison Invesco S&P SmallCap Health Care ETF has a beta of 1.020, suggesting its more volatile than the S&P 500 by 1.957%.
-
Which is a Better Dividend Stock PTH or PSCH?
Invesco Dorsey Wright Healthcare Momentum ETF has a quarterly dividend of $0.03 per share corresponding to a yield of 0.07%. Invesco S&P SmallCap Health Care ETF offers a yield of 0.29% to investors and pays a quarterly dividend of $0.02 per share. Invesco Dorsey Wright Healthcare Momentum ETF pays -- of its earnings as a dividend. Invesco S&P SmallCap Health Care ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PTH or PSCH?
Invesco Dorsey Wright Healthcare Momentum ETF quarterly revenues are --, which are smaller than Invesco S&P SmallCap Health Care ETF quarterly revenues of --. Invesco Dorsey Wright Healthcare Momentum ETF's net income of -- is lower than Invesco S&P SmallCap Health Care ETF's net income of --. Notably, Invesco Dorsey Wright Healthcare Momentum ETF's price-to-earnings ratio is -- while Invesco S&P SmallCap Health Care ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco Dorsey Wright Healthcare Momentum ETF is -- versus -- for Invesco S&P SmallCap Health Care ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PTHInvesco Dorsey Wright Healthcare Momentum ETF-- -- -- -- PSCHInvesco S&P SmallCap Health Care ETF-- -- -- --
-
Which has Higher Returns PTH or SBIO?
ALPS Medical Breakthroughs ETF has a net margin of -- compared to Invesco Dorsey Wright Healthcare Momentum ETF's net margin of --. Invesco Dorsey Wright Healthcare Momentum ETF's return on equity of -- beat ALPS Medical Breakthroughs ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PTHInvesco Dorsey Wright Healthcare Momentum ETF-- -- -- SBIOALPS Medical Breakthroughs ETF-- -- -- -
What do Analysts Say About PTH or SBIO?
Invesco Dorsey Wright Healthcare Momentum ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand ALPS Medical Breakthroughs ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco Dorsey Wright Healthcare Momentum ETF has higher upside potential than ALPS Medical Breakthroughs ETF, analysts believe Invesco Dorsey Wright Healthcare Momentum ETF is more attractive than ALPS Medical Breakthroughs ETF.
Company Buy Ratings Hold Ratings Sell Ratings PTHInvesco Dorsey Wright Healthcare Momentum ETF0 0 0 SBIOALPS Medical Breakthroughs ETF0 0 0 -
Is PTH or SBIO More Risky?
Invesco Dorsey Wright Healthcare Momentum ETF has a beta of 0.902, which suggesting that the stock is 9.824% less volatile than S&P 500. In comparison ALPS Medical Breakthroughs ETF has a beta of 0.934, suggesting its less volatile than the S&P 500 by 6.615%.
-
Which is a Better Dividend Stock PTH or SBIO?
Invesco Dorsey Wright Healthcare Momentum ETF has a quarterly dividend of $0.03 per share corresponding to a yield of 0.07%. ALPS Medical Breakthroughs ETF offers a yield of 3.85% to investors and pays a quarterly dividend of $1.17 per share. Invesco Dorsey Wright Healthcare Momentum ETF pays -- of its earnings as a dividend. ALPS Medical Breakthroughs ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PTH or SBIO?
Invesco Dorsey Wright Healthcare Momentum ETF quarterly revenues are --, which are smaller than ALPS Medical Breakthroughs ETF quarterly revenues of --. Invesco Dorsey Wright Healthcare Momentum ETF's net income of -- is lower than ALPS Medical Breakthroughs ETF's net income of --. Notably, Invesco Dorsey Wright Healthcare Momentum ETF's price-to-earnings ratio is -- while ALPS Medical Breakthroughs ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco Dorsey Wright Healthcare Momentum ETF is -- versus -- for ALPS Medical Breakthroughs ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PTHInvesco Dorsey Wright Healthcare Momentum ETF-- -- -- -- SBIOALPS Medical Breakthroughs ETF-- -- -- --
-
Which has Higher Returns PTH or XBI?
SPDR S&P Biotech ETF has a net margin of -- compared to Invesco Dorsey Wright Healthcare Momentum ETF's net margin of --. Invesco Dorsey Wright Healthcare Momentum ETF's return on equity of -- beat SPDR S&P Biotech ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PTHInvesco Dorsey Wright Healthcare Momentum ETF-- -- -- XBISPDR S&P Biotech ETF-- -- -- -
What do Analysts Say About PTH or XBI?
Invesco Dorsey Wright Healthcare Momentum ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand SPDR S&P Biotech ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco Dorsey Wright Healthcare Momentum ETF has higher upside potential than SPDR S&P Biotech ETF, analysts believe Invesco Dorsey Wright Healthcare Momentum ETF is more attractive than SPDR S&P Biotech ETF.
Company Buy Ratings Hold Ratings Sell Ratings PTHInvesco Dorsey Wright Healthcare Momentum ETF0 0 0 XBISPDR S&P Biotech ETF0 0 0 -
Is PTH or XBI More Risky?
Invesco Dorsey Wright Healthcare Momentum ETF has a beta of 0.902, which suggesting that the stock is 9.824% less volatile than S&P 500. In comparison SPDR S&P Biotech ETF has a beta of 1.028, suggesting its more volatile than the S&P 500 by 2.824%.
-
Which is a Better Dividend Stock PTH or XBI?
Invesco Dorsey Wright Healthcare Momentum ETF has a quarterly dividend of $0.03 per share corresponding to a yield of 0.07%. SPDR S&P Biotech ETF offers a yield of 0.15% to investors and pays a quarterly dividend of $0.00 per share. Invesco Dorsey Wright Healthcare Momentum ETF pays -- of its earnings as a dividend. SPDR S&P Biotech ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PTH or XBI?
Invesco Dorsey Wright Healthcare Momentum ETF quarterly revenues are --, which are smaller than SPDR S&P Biotech ETF quarterly revenues of --. Invesco Dorsey Wright Healthcare Momentum ETF's net income of -- is lower than SPDR S&P Biotech ETF's net income of --. Notably, Invesco Dorsey Wright Healthcare Momentum ETF's price-to-earnings ratio is -- while SPDR S&P Biotech ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco Dorsey Wright Healthcare Momentum ETF is -- versus -- for SPDR S&P Biotech ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PTHInvesco Dorsey Wright Healthcare Momentum ETF-- -- -- -- XBISPDR S&P Biotech ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Tesla Stock: The Bear Case
The recent stock market drop has been a punishing time…
Is VUG a Good ETF to Buy?
For the last few years, earnings growth from the tech…
Stock Ideas
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 34x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Sell
47
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Alerts
Sell
5
CABO alert for Mar 14
Cable One [CABO] is down 3.63% over the past day.
Sell
38
ADBE alert for Mar 14
Adobe [ADBE] is up 4.45% over the past day.
Sell
29
CAR alert for Mar 14
Avis Budget Group [CAR] is up 11.66% over the past day.
